This High-Yield Dividend Portfolio Will Beat the Market
Published Mon, 28 Mar 2011 on The Motley Fool

Over the past two weeks, the S&P 500 rose a slight 0.35%. Our portfolio maintained its outperformance of the market, extending its lead to 1.56 percentage points! While outperformance is always good, it should be taken with a grain of salt. We're investing for the long term, and it's only been five weeks. But I firmly believe the results will bear us out. Movers & shakersOf our stocks, the biggest mover in the portfolio the past two weeks was Bristol-Myers Squibb, which rose 3.33%. The stock jumped on Friday when, as Fool pharma analyst Brian Orelli expected, the FDA approved the firm's melanoma drug Yervoy . The drug is a breakthrough in that it is the first time a drug has significantly extended survival for melanoma patients.... Read more